PSC Partners Seeking a Cure Award, AASLD, 2007

[Guest guest]

Dear All,

As many of you will be aware, PSC Partners Seeking a Cure will award

a $3,000 prize annually at the annual meeting of the American

Association for the Study of Liver Diseases (AASLD).

This is how the award is listed on the AASLD web site:

__________________

PSC Partners Seeking a Cure Award

$3,000 (1 available)

This award shall be given to one investigator presenting the most

promising PSC research at The Liver Meeting® 2007. All abstracts

submitted to the Human Cholestatic and Autoimmune Liver Diseases

Category, PSC descriptor will be considered for this award (there is

not a formal application process for this award). Notification will

be made in August. This award can be used to support travel and

accommodation expenses associated with participation in the AASLD

Annual Meeting, or for supplies and expenses for PSC research.

The awardee will also be invited to attend the PSC Partners Seeking a

Cure Annual Conference (www.pscpartners.org).

AASLD gratefully acknowledges PSC Partners Seeking a Cure for their

generous support of this award.

__________________

I received the following message from AASLD this afternoon (see

attached message below) indicating that a selection has been made for

a recipient of the 2007 PSC Partners Seeking a Cure award. The

recipient will be: Dr. Tom H. Karlsen, who will present his research

(HLA Association in Primary Sclerosing Cholangitis: Detection and

Finemapping of an HLA Independent signal in the Complement Gene

Cluster) during the Molecular Advances in human Cholestatic Liver

Disease Parallel Session at the Liver Meeting®, AASLD 58th Annual

Meeting.

Ricky and Deb will take care of payment of the award. Dr. Gegory

Everson will be attending the reception on November 3, 2007, and will

give the award.

Dr. Karlsen is doing some really fine work on the genetics of PSC and

IBD, and he would seem like an excellent choice for the award. Here

are some of his recent papers:

e A, Rosenstiel P, Balschun T, Von Kampen O, Schreiber S, Sina

C, Hampe J, Karlsen TH, Vatn MH; IBSEN Study Group, Solberg C. No

association between the TUCAN (CARD8) Cys10Stop mutation and

inflammatory bowel disease in a large retrospective German and a

clinically well-characterized Norwegian sample. Gastroenterology.

2007 May;132(5):2080-1. PMID: 17484912.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A,

Schrumpf E, Thorsby E, Lie BA. Particular genetic variants of ligands

for natural killer cell receptors may contribute to the HLA

associated risk of primary sclerosing cholangitis. J Hepatol. 2007

May;46(5):899-906. PMID: 17383044.

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E,

Thorsby E, Schreiber S, Lie BA; IBSEN Study Group. Different HLA

class II associations in ulcerative colitis patients with and without

primary sclerosing cholangitis. Genes Immun. 2007 Apr;8(3):275-8.

PMID: 17301827.

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA,

Spurkland A. Primary sclerosing cholangitis is associated with

extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens. 2007 Feb;69

(2):161-9. PMID: 17257319.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome

U, Schreiber S, Boberg KM. Genetic polymorphisms associated with

inflammatory bowel disease do not confer risk for primary sclerosing

cholangitis. Am J Gastroenterol. 2007 Jan;102(1):115-21. Epub 2006

Nov 13. PMID: 17100974.

e A, Ruether A, Wedemeyer N, Karlsen TH, Nebel A, Schreiber S.

No association between the functional CARD4 insertion/deletion

polymorphism and inflammatory bowel diseases in the German

population. Gut. 2006 Nov;55(11):1679-80. PMID: 17047129.

Karlsen TH, Lie BA, Frey Froslie K, Thorsby E, Broome U, Schrumpf E,

Boberg KM. Polymorphisms in the steroid and xenobiotic receptor gene

influence survival in primary sclerosing cholangitis.

Gastroenterology. 2006 Sep;131(3):781-7. PMID: 16952547.

Melum E, Karlsen TH, Broome U, Thorsby E, Schrumpf E, Boberg KM, Lie

BA. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-

Delta32) is not associated with primary sclerosing cholangitis in 363

Scandinavian patients. Tissue Antigens. 2006 Jul;68(1):78-81. PMID:

16774544.

Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M, Schrumpf E, Lie

BA, Boberg KM.Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365

Scandinavian patients with primary sclerosing cholangitis. J Hepatol.

2006 Nov;45(5):704-10. PMID: 16750586.

Dr. Karlsen's address is: Medical Department, Rikshospitalet-

Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway.

Our PSC support group members of Scandinavian heritage, origin and/or

abode should be particularly pleased!

Ricky will extend an invitation to Dr. Karlsen to attend the 2008 PSC

Partners Seeking a Cure Conference in ville, FL.

Personally I am thrilled that PSC Partners Seeking a Cure will

establish a relationship with Dr. Karlsen, and will be recognized at

the AASLD meeting. Thank you to everyone who has made this

possible!!!

Best regards,

Dave

PSC Award

Dr. -

The AASLD would like thank PSC Partners Seeking a Cure for their

generous $3,000 contribution for the support an award to an applicant

with promising research in the field of PSC. We are happy to announce

the AASLD Scientific Program Committee has selected a Liver Meeting®

abstract to receive this award. Dr. Tom H. Karlsen will present his

research (HLA Association in Primary Sclerosing Cholangitis:

Detection and Finemapping of an HLA Independent signal in the

Complement Gene Cluster) during the Molecular Advances in human

Cholestatic Liver Disease Parallel Session at the Liver Meeting®,

AASLD 58th Annual Meeting. AASLD will recognize PSC and the award

recipient in our conference materials and signage. In addition, we

will have a reception (Saturday, November 3, 7:00pm) that honors

award winners. We would like to extend an invitation to you to attend

this reception.

Again, we appreciate your support of this award. A check will be

distributed to the recipient at the meeting. I have enclosed an

invoice for the committed amount. Should you have questions please

don't hesitate to contact me.

Best regards,

Janeil Klett

AASLD

[Guest guest]

,

This is very exciting. And yes, as a Swede, I'm tickled that it went to a

Scandinavian researcher. I'm hoping to make it to the next PSC seminar - it

would be nice to actually meet Tom Karlsen.

-Marie

>Dr. Karlsen's address is: Medical Department, Rikshospitalet-

>Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway.

>Our PSC support group members of Scandinavian heritage, origin and/or

>abode should be particularly pleased!

>

_________________________________________________________________

Now you can see trouble…before he arrives

http://newlivehotmail.com/?ocid=TXT_TAGHM_migration_HM_viral_protection_0507

[Guest guest]

Thanks so much Dave for posting this great news to the group.Together in the fight, whatever it takes.LeeDear All,As many of you will be aware, PSC Partners Seeking a Cure will award a $3,000 prize annually at the annual meeting of the American Association for the Study of Liver Diseases (AASLD). This is how the award is listed on the AASLD web site:__________________PSC Partners Seeking a Cure Award$3,000 (1 available) This award shall be given to one investigator presenting the most promising PSC research at The Liver Meeting® 2007. All abstracts submitted to the Human Cholestatic and Autoimmune Liver Diseases Category, PSC descriptor will be considered for this award (there is not a formal application process for this award). Notification will be made in August. This award can be used to support travel and accommodation expenses associated with participation in the AASLD Annual Meeting, or for supplies and expenses for PSC research. The awardee will also be invited to attend the PSC Partners Seeking a Cure Annual Conference (www.pscpartners.org). AASLD gratefully acknowledges PSC Partners Seeking a Cure for their generous support of this award. __________________I received the following message from AASLD this afternoon (see attached message below) indicating that a selection has been made for a recipient of the 2007 PSC Partners Seeking a Cure award. The recipient will be: Dr. Tom H. Karlsen, who will present his research (HLA Association in Primary Sclerosing Cholangitis: Detection and Finemapping of an HLA Independent signal in the Complement Gene Cluster) during the Molecular Advances in human Cholestatic Liver Disease Parallel Session at the Liver Meeting®, AASLD 58th Annual Meeting.

[Guest guest]

I am so proud to be a part of this group –

thank you , Ricki, Deb, Lee and all others who were involved.

LINDA

(Mom of Suzanne, 18; UC 1/04; PSC 3/04; jpouch 2/07)

From:

[mailto: ] On Behalf Of

Sent: Wednesday, August 15, 2007

12:16 AM

To:

Subject: PSC

Partners Seeking a Cure Award, AASLD, 2007

Dear All,

As many of you will be aware, PSC Partners Seeking a Cure will award

a $3,000 prize annually at the annual meeting of the American

Association for the Study of Liver Diseases (AASLD).

This is how the award is listed on the AASLD web site:

__________________

PSC Partners Seeking a Cure Award

$3,000 (1 available)

This award shall be given to one investigator presenting the most

promising PSC research at The Liver Meeting® 2007. All abstracts

submitted to the Human Cholestatic and Autoimmune Liver Diseases

Category, PSC descriptor will be considered for this award (there is

not a formal application process for this award). Notification will

be made in August. This award can be used to support travel and

accommodation expenses associated with participation in the AASLD

Annual Meeting, or for supplies and expenses for PSC research.

The awardee will also be invited to attend the PSC Partners Seeking a

Cure Annual Conference (www.pscpartners.org).

AASLD gratefully acknowledges PSC Partners Seeking a Cure for their

generous support of this award.

__________________

I received the following message from AASLD this afternoon (see

attached message below) indicating that a selection has been made for

a recipient of the 2007 PSC Partners Seeking a Cure award. The

recipient will be: Dr. Tom H. Karlsen, who will present his research

(HLA Association in Primary Sclerosing Cholangitis: Detection and

Finemapping of an HLA Independent signal in the Complement Gene

Cluster) during the Molecular Advances in human Cholestatic Liver

Disease Parallel Session at the Liver Meeting®, AASLD 58th Annual

Meeting.

Ricky and Deb will take care of payment of the award. Dr. Gegory

Everson will be attending the reception on November 3, 2007, and will

give the award.

Dr. Karlsen is doing some really fine work on the genetics of PSC and

IBD, and he would seem like an excellent choice for the award. Here

are some of his recent papers:

e A, Rosenstiel P, Balschun T, Von Kampen O, Schreiber S, Sina

C, Hampe J, Karlsen TH, Vatn MH; IBSEN Study Group, Solberg C. No

association between the TUCAN (CARD8) Cys10Stop mutation and

inflammatory bowel disease in a large retrospective German and a

clinically well-characterized Norwegian sample. Gastroenterology.

2007 May;132(5):2080-1. PMID: 17484912.

Karlsen TH, Boberg KM, Olsson M, Sun JY, Senitzer D, Bergquist A,

Schrumpf E, Thorsby E, Lie BA. Particular genetic variants of ligands

for natural killer cell receptors may contribute to the HLA

associated risk of primary sclerosing cholangitis. J Hepatol. 2007

May;46(5):899-906. PMID: 17383044.

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E,

Thorsby E, Schreiber S, Lie BA; IBSEN Study Group. Different HLA

class II associations in ulcerative colitis patients with and without

primary sclerosing cholangitis. Genes Immun. 2007 Apr;8(3):275-8.

PMID: 17301827.

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA,

Spurkland A. Primary sclerosing cholangitis is associated with

extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens. 2007 Feb;69

(2):161-9. PMID: 17257319.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broome

U, Schreiber S, Boberg KM. Genetic polymorphisms associated with

inflammatory bowel disease do not confer risk for primary sclerosing

cholangitis. Am J Gastroenterol. 2007 Jan;102(1):115-21. Epub 2006

Nov 13. PMID: 17100974.

e A, Ruether A, Wedemeyer N, Karlsen TH, Nebel A, Schreiber S.

No association between the functional CARD4 insertion/deletion

polymorphism and inflammatory bowel diseases in the German

population. Gut. 2006 Nov;55(11):1679-80. PMID: 17047129.

Karlsen TH, Lie BA, Frey Froslie K, Thorsby E, Broome U, Schrumpf E,

Boberg KM. Polymorphisms in the steroid and xenobiotic receptor gene

influence survival in primary sclerosing cholangitis.

Gastroenterology. 2006 Sep;131(3):781-7. PMID: 16952547.

Melum E, Karlsen TH, Broome U, Thorsby E, Schrumpf E, Boberg KM, Lie

BA. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-

Delta32) is not associated with primary sclerosing cholangitis in 363

Scandinavian patients. Tissue Antigens. 2006 Jul;68(1):78-81. PMID:

16774544.

Bowlus CL, Karlsen TH, Broome U, Thorsby E, Vatn M, Schrumpf E, Lie

BA, Boberg KM.Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365

Scandinavian patients with primary sclerosing cholangitis. J Hepatol.

2006 Nov;45(5):704-10. PMID: 16750586.

Dr. Karlsen's address is: Medical Department, Rikshospitalet-

Radiumhospitalet Medical

Center, University

of Oslo, Oslo, Norway.

Our PSC support group members of Scandinavian heritage, origin and/or

abode should be particularly pleased!

Ricky will extend an invitation to Dr. Karlsen to attend the 2008 PSC

Partners Seeking a Cure Conference in ville,

FL.

Personally I am thrilled that PSC Partners Seeking a Cure will

establish a relationship with Dr. Karlsen, and will be recognized at

the AASLD meeting. Thank you to everyone who has made this

possible!!!

Best regards,

Dave

PSC Award

Dr. -

The AASLD would like thank PSC Partners Seeking a Cure for their

generous $3,000 contribution for the support an award to an applicant

with promising research in the field of PSC. We are happy to announce

the AASLD Scientific Program Committee has selected a Liver Meeting®

abstract to receive this award. Dr. Tom H. Karlsen will present his

research (HLA Association in Primary Sclerosing Cholangitis:

Detection and Finemapping of an HLA Independent signal in the

Complement Gene Cluster) during the Molecular Advances in human

Cholestatic Liver Disease Parallel Session at the Liver Meeting®,

AASLD 58th Annual Meeting. AASLD will recognize PSC and the award

recipient in our conference materials and signage. In addition, we

will have a reception (Saturday, November 3, 7:00pm) that honors

award winners. We would like to extend an invitation to you to attend

this reception.

Again, we appreciate your support of this award. A check will be

distributed to the recipient at the meeting. I have enclosed an

invoice for the committed amount. Should you have questions please

don't hesitate to contact me.

Best regards,

Janeil Klett

AASLD

[Guest guest]

Your thanks are appreciated !!Together in the fight , whatever it takes LeeI am so proud to be a part of this group – thank you , Ricki, Deb, Lee and all others who were involved. LINDA(Mom of Suzanne, 18; UC 1/04; PSC 3/04; jpouch 2/07)